News & Updates

Ustekinumab yields sustained clinical benefit in systemic lupus erythematosus

17 Jan 2020

Use of ustekinumab in the treatment of systemic lupus erythematosus leads to significant improvements in many of the efficacy indices evaluated, with lower risk of flares and sustained response rates, when compared with placebo, according to 1-year data from a phase II trial.

Ustekinumab yields sustained clinical benefit in systemic lupus erythematosus

17 Jan 2020

$Parkinson’s disease carries heightened risk of hip, nonvertebral fractures$

Parkinson’s disease carries heightened risk of hip, nonvertebral fractures

16 Jan 2020

Patients with Parkinson’s disease are at high risk of hip and nonvertebral fractures, as shown in a recent study.

Parkinson’s disease carries heightened risk of hip, nonvertebral fractures

16 Jan 2020

Few gout patients on ULT despite high disease burden in SG

15 Jan 2020 by

Despite the substantial disease burden from gout in Singapore — with a majority of the patients not being at the serum urate (SU) target, only two-thirds of the patients receive urate-lowering therapy (ULT), according to a local study.

Few gout patients on ULT despite high disease burden in SG

15 Jan 2020

Cardiac magnetic resonance findings predict rhythm disturbances in scleroderma

14 Jan 2020

Oedema and late gadolinium enhancement on cardiovascular magnetic resonance are highly predictive of rhythm disturbances in patients with systemic sclerosis (SSc), a study has found.

Cardiac magnetic resonance findings predict rhythm disturbances in scleroderma

14 Jan 2020

Renin-angiotensin system components enriched in RA vs OA patients

14 Jan 2020

Components of the renin-angiotensin system (RAS), such as renin, angiotensin-converting enzyme (ACE), matrix metalloproteinase-13 (MMP-13) and vascular endothelial growth factor (VEGF), are more elevated in the synovial fluid of patients with rheumatoid arthritis (RA) than with osteoarthritis (OA), a recent study has shown.

Renin-angiotensin system components enriched in RA vs OA patients

14 Jan 2020

Electrical nerve stimulation helps mitigate movement-evoked pain in fibromyalgia

12 Jan 2020

Use of active transcutaneous electrical nerve stimulation (TENS) in fibromyalgia (FM) patients receiving treatment results in a favourable reduction in movement-evoked pain, according to the results of a trial.

Electrical nerve stimulation helps mitigate movement-evoked pain in fibromyalgia

12 Jan 2020

TNF-α inhibitors on par with novel biologics for resolution of dactylitis, enthesitis

12 Jan 2020

Tumour necrosis factor-α (TNF-α) inhibitors infliximab, golimumab and adalimumab are as effective as novel biologic agents ustekinumab, secukinumab and ixekizumab in the treatment of dactylitis and enthesitis, results of a systematic review and meta-analysis have shown.

TNF-α inhibitors on par with novel biologics for resolution of dactylitis, enthesitis

12 Jan 2020

Guidelines on osteoporosis treatment poorly implemented in RA patients

11 Jan 2020

Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Guidelines on osteoporosis treatment poorly implemented in RA patients

11 Jan 2020

Novel selective cathepsin K inhibitor safely reduces bone, cartilage progression in osteoarthritis

08 Jan 2020

The new selective cathepsin K inhibitor MIV-711 does not perform better than placebo in easing osteoarthritic pain, a study has shown. However, it substantially decreases bone and cartilage progression with a reassuring safety profile.

Novel selective cathepsin K inhibitor safely reduces bone, cartilage progression in osteoarthritis

08 Jan 2020

Osteoporosis a growing threat in Singapore

27 Dec 2019 by

The incidence of osteoporotic fractures is expected to grow by more than 50 percent, according to a recent Singapore study. This will be accompanied by a spike in economic burden, both directly and indirectly associated with healthcare.

Osteoporosis a growing threat in Singapore

27 Dec 2019

News & Updates

Filter by Specialty:

Specialty:

Ustekinumab yields sustained clinical benefit in systemic lupus erythematosus

Ustekinumab yields sustained clinical benefit in systemic lupus erythematosus

Parkinson’s disease carries heightened risk of hip, nonvertebral fractures

Parkinson’s disease carries heightened risk of hip, nonvertebral fractures

Few gout patients on ULT despite high disease burden in SG

Few gout patients on ULT despite high disease burden in SG

Cardiac magnetic resonance findings predict rhythm disturbances in scleroderma

Cardiac magnetic resonance findings predict rhythm disturbances in scleroderma

Renin-angiotensin system components enriched in RA vs OA patients

Renin-angiotensin system components enriched in RA vs OA patients

Electrical nerve stimulation helps mitigate movement-evoked pain in fibromyalgia

Electrical nerve stimulation helps mitigate movement-evoked pain in fibromyalgia

TNF-α inhibitors on par with novel biologics for resolution of dactylitis, enthesitis

TNF-α inhibitors on par with novel biologics for resolution of dactylitis, enthesitis

Guidelines on osteoporosis treatment poorly implemented in RA patients

Guidelines on osteoporosis treatment poorly implemented in RA patients

Novel selective cathepsin K inhibitor safely reduces bone, cartilage progression in osteoarthritis

Novel selective cathepsin K inhibitor safely reduces bone, cartilage progression in osteoarthritis

Osteoporosis a growing threat in Singapore

Osteoporosis a growing threat in Singapore